Gamze Serarslan

678 total citations
36 papers, 435 citations indexed

About

Gamze Serarslan is a scholar working on Dermatology, Rheumatology and Cell Biology. According to data from OpenAlex, Gamze Serarslan has authored 36 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Dermatology, 9 papers in Rheumatology and 7 papers in Cell Biology. Recurrent topics in Gamze Serarslan's work include Urticaria and Related Conditions (6 papers), Research on Leishmaniasis Studies (5 papers) and Dermatology and Skin Diseases (5 papers). Gamze Serarslan is often cited by papers focused on Urticaria and Related Conditions (6 papers), Research on Leishmaniasis Studies (5 papers) and Dermatology and Skin Diseases (5 papers). Gamze Serarslan collaborates with scholars based in Türkiye, China and United States. Gamze Serarslan's co-authors include Esin Atık, Nigar Yılmaz, Zafer Yönden, H. Ramazan Yılmaz, Gülden Avcı, Kemal Türker Ulutaş, Nazan Savaş, Sinem Karazincir, Hayal Güler and Ferit Akgül and has published in prestigious journals such as SHILAP Revista de lepidopterología, Multiple Sclerosis Journal and Otolaryngology.

In The Last Decade

Gamze Serarslan

32 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gamze Serarslan Türkiye 13 134 102 75 73 69 36 435
K.H. Cho South Korea 8 187 1.4× 94 0.9× 38 0.5× 45 0.6× 63 0.9× 12 420
Ladan Dastgheib Iran 11 126 0.9× 65 0.6× 52 0.7× 51 0.7× 76 1.1× 39 401
Seung Phil Hong South Korea 13 407 3.0× 112 1.1× 48 0.6× 55 0.8× 69 1.0× 48 692
David B. Vasily United States 12 181 1.4× 24 0.2× 53 0.7× 83 1.1× 58 0.8× 18 413
Ruiming Hu China 14 141 1.1× 203 2.0× 104 1.4× 55 0.8× 58 0.8× 31 532
Seok‐Kweon Yun South Korea 12 228 1.7× 64 0.6× 139 1.9× 32 0.4× 83 1.2× 75 485
Constantin E. Orfanos Germany 9 455 3.4× 92 0.9× 89 1.2× 62 0.8× 128 1.9× 12 763
Yasuyuki Sumikawa Japan 16 249 1.9× 34 0.3× 82 1.1× 174 2.4× 126 1.8× 36 658
Aunna Pourang United States 14 192 1.4× 39 0.4× 46 0.6× 40 0.5× 74 1.1× 32 391
Vedrana Bulat Croatia 13 221 1.6× 18 0.2× 114 1.5× 69 0.9× 88 1.3× 39 471

Countries citing papers authored by Gamze Serarslan

Since Specialization
Citations

This map shows the geographic impact of Gamze Serarslan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gamze Serarslan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gamze Serarslan more than expected).

Fields of papers citing papers by Gamze Serarslan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gamze Serarslan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gamze Serarslan. The network helps show where Gamze Serarslan may publish in the future.

Co-authorship network of co-authors of Gamze Serarslan

This figure shows the co-authorship network connecting the top 25 collaborators of Gamze Serarslan. A scholar is included among the top collaborators of Gamze Serarslan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gamze Serarslan. Gamze Serarslan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serarslan, Gamze, et al.. (2022). Association of MEFV mutations and vascular involvement in Behcet’s disease: a study from Hatay, Turkey. Reumatologia/Rheumatology. 60(3). 220–223. 2 indexed citations
2.
Serarslan, Gamze, et al.. (2021). Scale and Pustule on Dermoscopy of Rosacea: A Diagnostic Clue for Demodex Species. Dermatology Practical & Conceptual. 11(1). e2021139–e2021139. 8 indexed citations
4.
Serarslan, Gamze. (2020). Clinical Characteristics and Treatment Outcomes in Patients with Urticarial Vasculitis. Northern Clinics of Istanbul. 8(5). 513–517. 5 indexed citations
5.
Serarslan, Gamze, et al.. (2020). Role of adiponectin and leptin in patients with alopecia areata with scalp hair loss. Irish Journal of Medical Science (1971 -). 190(3). 1015–1020. 12 indexed citations
6.
Serarslan, Gamze, et al.. (2019). Evaluation of clinical and demographic characteristics of Turkish and Syrian pediatric cutaneous leishmaniasis patients from Hatay, Turkey after the Syrian civil war. Advances in Dermatology and Allergology. 37(2). 229–233. 2 indexed citations
7.
Serarslan, Gamze, et al.. (2019). Dermoscopy in the Diagnosis of Cutaneous Leishmaniasis. Dermatology Practical & Conceptual. 9(2). 111–118. 15 indexed citations
8.
Serarslan, Gamze, et al.. (2011). Periorbital edema and erythema: An unusual localization of DLE in a patient with psoriasis. The Journal of Dermatology. 38(5). 486–488. 7 indexed citations
9.
Serarslan, Gamze, et al.. (2011). Is atopy and autoimmunity more prevalent in patients with alopecia areata? A comparative study. Journal of the European Academy of Dermatology and Venereology. 26(6). 720–723. 17 indexed citations
10.
Serarslan, Gamze, et al.. (2009). The prevalence of pruritus in Mustafa Kemal University Dermatology Outpatient Clinic during July 2008. Balkan Medical Journal. 2009(2). 1 indexed citations
11.
Serarslan, Gamze, Ferit Akgül, & Cenk Babayiğit. (2009). High Prevalence of Pulmonary Hypertension in Homozygous Sickle Cell Patients with Leg Ulceration. Clinical and Experimental Hypertension. 31(1). 44–48. 14 indexed citations
12.
Serarslan, Gamze, et al.. (2009). Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease. Clinical and Experimental Dermatology. 35(5). 487–490. 22 indexed citations
13.
Serarslan, Gamze, et al.. (2007). Kafeik asid fenetil ester'in insizyonel yara modelinde plazma lipid peroksidasyonu, antioksidan durum ve nitrik oksit seviyesi üzerine etkisi. 41(1). 11–14. 1 indexed citations
14.
Serarslan, Gamze, et al.. (2007). Caffeic acid phenetyl ester accelerates cutaneous wound healing in a rat model and decreases oxidative stress. Clinical and Experimental Dermatology. 32(6). 709–715. 59 indexed citations
15.
Serarslan, Gamze, et al.. (2007). Widespread maculopapular rash due to intramuscular interferon beta-1a during the treatment of multiple sclerosis. Multiple Sclerosis Journal. 14(2). 259–261. 11 indexed citations
16.
Reyhan, Mehmet, et al.. (2007). Sickle Cell Disease With Regional Silent Cerebral Infarction Detected by SPECT. Clinical Nuclear Medicine. 32(11). 842–843. 3 indexed citations
17.
Serarslan, Gamze, Hayal Güler, & Sinem Karazincir. (2006). The relationship between nail- and distal phalangeal bone involvement severity in patients with psoriasis. Clinical Rheumatology. 26(8). 1245–1247. 16 indexed citations
18.
Serarslan, Gamze & Esin Atık. (2004). A case report of sporotrichosis from Turkey. American Journal of Case Reports. 5. 297–299.
19.
Akçalı, Kamil Can, et al.. (2004). The Laugier-Hunziker Syndrome. East African Medical Journal. 81(10). 544–5. 5 indexed citations
20.
Serarslan, Gamze, et al.. (2003). Acral lentiginous melanoma misdiagnosed as tinea pedis: a case report. International Journal of Dermatology. 43(1). 37–38. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026